Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 May;23(3):291-7.
doi: 10.1097/01.mnh.0000444821.87873.7b.

Cognitive and physical function in chronic kidney disease

Affiliations
Review

Cognitive and physical function in chronic kidney disease

Daniel E Weiner et al. Curr Opin Nephrol Hypertens. 2014 May.

Abstract

Purpose of review: Both cognitive and physical function are commonly impaired in individuals with chronic kidney disease (CKD), resulting in important impacts on their quality of life and overall health. This review summarizes the burden of cognitive and physical impairment in CKD, focusing on recent research that highlights a possible unifying microvascular cause among these shared comorbid conditions.

Recent findings: Multiple small studies have been published recently evaluating cognitive and physical functioning in people with CKD. These studies overall demonstrate a high burden of comorbid conditions in people with CKD, including microvascular disease, that may result in cognitive impairment. Additionally, studies demonstrate that physical function is substantially worse than expected in individuals with CKD, that decreased physical activity is associated with worse outcomes, that frailty is very common and associated with an increased risk of death, and that structured exercise programs have small but tangible short-term effects on markers of physical performance.

Summary: Impaired cognitive function and physical performance are important factors impacting the lives of people with CKD. Further research is necessary to better treat these important comorbid conditions in people with CKD.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Concept diagram of the development of and effects of cardiovascular and cerebrovascular disease in CKD, presenting the transition from cardiovascular disease risk factors, including CKD, to clinical outcomes, including cognitive and physical impairment, mediated by microvascular disease.

References

    1. Bowling CB, Sharma P, Fox CS, O’Hare AM, Muntner P. Prevalence of reduced estimated glomerular filtration rate among the oldest old from 1988-1994 through 2005-2010. JAMA. 2013;310:1284–6. - PMC - PubMed
    1. Grams ME, Chow EK, Segev DL, Coresh J. Lifetime incidence of CKD stages 3-5 in the United States. Am J Kidney Dis. 2013;62:245–52. - PMC - PubMed
    1. Bowling CB, Muntner P, Sawyer P, et al. Community Mobility Among Older Adults With Reduced Kidney Function: A Study of Life-Space. Am J Kidney Dis. 2013 - PMC - PubMed
    1. Bowling CB, O’Hare AM. Managing older adults with CKD: individualized versus disease-based approaches. Am J Kidney Dis. 2012;59:293–302. - PMC - PubMed
    1. Kurella Tamura M, Muntner P, Wadley V, et al. Albuminuria, kidney function, and the incidence of cognitive impairment among adults in the United States. Am J Kidney Dis. 2011;58:756–63. - PMC - PubMed

Publication types

MeSH terms